Results 1 to 10 of about 1,437 (141)

SAPHO Syndrome Complicated by Ankylosing Spondylitis Successfully Treated With Tofacitinib: A Case Report

open access: yesFrontiers in Immunology, 2022
Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome, a type of chronic inflammatory disease, is rare and difficult to treat. Osteoarthropathy with skin involvement is the primary clinical manifestation of SAPHO syndrome.
Fangfang Yuan, Jing Luo, Qiong Yang
doaj   +3 more sources

Family aggregation and prevalence of other autoimmune diseases in SAPHO syndrome

open access: yesHeliyon, 2023
Objective: SAPHO (Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis) syndrome is a heterogeneous disease that clinically manifests as chronic inflammatory osteoarticular and dermatological lesions.
Chen Li   +6 more
doaj   +3 more sources

Evaluation of tonsillectomy in the treatment of SAPHO syndrome: past evidence and future directions [PDF]

open access: yesFrontiers in Medicine
Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare aseptic inflammatory clinical syndrome characterized by widespread skin lesions and bone-joint lesions.
Wen-Yuan Gan   +3 more
doaj   +2 more sources

Upadacitinib in the treatment of SAPHO syndrome: a case report [PDF]

open access: yesFrontiers in Immunology
Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome, a rare autoinflammatory disease, is usually defined by musculoskeletal symptoms and cutaneous manifestations.
Yanran Yang, Zhanxue Sun, Yongpeng Ge
doaj   +2 more sources

SAPHO syndrome and pustular skin diseases: shared inflammatory circuits, divergent tissue outcomes, and the limits of a spectrum model [PDF]

open access: yesFrontiers in Immunology
Both SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome and pustular skin diseases are characterized by neutrophil-dominated inflammatory responses; however, whether they represent manifestations within a shared disease spectrum ...
Rongzhen Xia   +7 more
doaj   +2 more sources

Postpartum lumbopelvic pain could be SAPHO syndrome: a case report [PDF]

open access: yesFrontiers in Immunology
BackgroundSynovitis–acne–pustulosis–hyperostosis–osteitis (SAPHO) syndrome is a rare autoimmune disorder. The involvement of spinal and sacroiliac joint in SAPHO syndrome closely resembles the manifestations of postpartum lumbopelvic pain (LPP).Case ...
Zheng Weiwei, Zhang Junhong, Zhang Rong
doaj   +2 more sources

Familial clustering of SAPHO syndrome. [PDF]

open access: yesCent Eur J Immunol
In a novel investigation of familial aggregation in SAPHO syndrome, a rare chronic autoinflammatory disorder characterized by the acronym synovitis, acne, pustulosis, hyperostosis, and osteitis, we identified a unique familial cohort with four affected individuals, including a male, marking the first report of male familial involvement in the ...
Gu M   +5 more
europepmc   +4 more sources

The role of cytokines in the pathogenesis of SAPHO syndrome [PDF]

open access: yesFrontiers in Immunology
SAPHO syndrome is a complex inflammatory disorder affecting the skin and bones, characterized by osteomyelitis, acne, and pustulosis. Cytokines play a pivotal role in the pathogenesis of SAPHO syndrome, especially in inflammatory responses and immune ...
Yi Yang   +5 more
doaj   +2 more sources

Enteropathic SAPHO Syndrome in Ulcerative Colitis Responsive to Bisphosphonates [PDF]

open access: yesCase Reports in Rheumatology
SAPHO syndrome, a rare inflammatory disorder of bone, joints, and skin, is named based on the presence of synovitis, acne, pustulosis, hyperostosis, and osteitis.
Jordan Phillipps   +6 more
doaj   +2 more sources

Coexistence of SAPHO syndrome and IgG4‐related disease with Upadacitinib [PDF]

open access: yesClinical & Translational Immunology
Objectives To describe the first reported case of coexisting Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) syndrome and IgG4‐related disease (IgG4‐RD) and to evaluate the therapeutic response to Upadacitinib.
Hang Zhou   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy